Recall of Cannabis for Medical Purposes - Aphria

Starting date:

March 8, 2017

Type of communication:

Drug Recall

Subcategory:

Drugs

Hazard classification:

Type III

Source of recall:

Health Canada

Issue:

Labelling and Packaging

Audience:

General Public

Identification number:

RA-62620

• Reason
• Affected products
• Media enquiries

Introduction

On March 8, 2017, Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary recall of one lot of dried marijuana under a Type III recall. The affected lot number can be found below.

Reason

On March 8, 2017, Aphria initiated a voluntary Type III recall for one lot of product due to the mislabelling of the delta-9-tetrahydrocannabidiol (THC) content of the products. The THC content identified on the label was higher than the concentration present in the products. The products were mislabelled as containing 22.3% THC instead of 21.1% THC.

A Type III recall refers to a situation in which the use of, or exposure to a product, is not likely to cause any adverse health consequences.

To date, Health Canada has not received any adverse reaction reports for products sold by Aphria. However, Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and to contact Aphria at the following number 1-844-427-4742.

Affected products

Media enquiries

Santé Canada
(613) 957-2983